KUKJEON PHARMACEUTICAL Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '25 Mar 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	11,307	46,824	10,992	21,546	19,099
Short-Term Investments	-	-	15,000	45,000	20,160
Trading Asset Securities	27,275	-	38,840	28,425	-
Cash & Short-Term Investments	38,582	46,824	64,833	94,971	39,259
Cash Growth	-34.02%	-27.78%	-31.73%	141.91%	-
Accounts Receivable	34,478	28,779	26,850	21,923	20,015
Other Receivables	1,208	66.66	1,964	867.93	194.62
Receivables	36,106	29,255	29,065	23,403	20,409
Inventory	26,264	26,798	27,563	20,209	16,207
Prepaid Expenses	-	538.53	494.91	246.48	143.8
Other Current Assets	2,233	1,773	2,036	4,064	896.09
Total Current Assets	103,185	105,189	123,992	142,893	76,915
Property, Plant & Equipment	86,144	87,360	86,060	46,118	24,026
Long-Term Investments	5,185	5,322	4,364	3,173	3,493
Goodwill	420.39	420.39	420.39	420.39	-
Other Intangible Assets	928.27	908.17	971	903.51	422.37
Long-Term Deferred Tax Assets	2,046	2,185	1,964	-	794.9
Long-Term Deferred Charges	3,500	3,500	-	-	-
Other Long-Term Assets	6,859	7,169	7,090	2,379	517.79
Total Assets	208,528	212,273	225,102	196,097	106,989
Accounts Payable	23,097	17,833	11,693	9,474	10,989
Accrued Expenses	305.27	359.99	289.73	178.99	83.02
Short-Term Debt	30,439	8,560	15,224	7,883	5,133
Current Portion of Long-Term Debt	2,777	31,819	36,802	26,015	1,457
Current Portion of Leases	203.94	274.88	236.17	147.15	124.88
Current Income Taxes Payable	-	-	-	-	1,057
Current Unearned Revenue	-	-	35.16	-	-
Other Current Liabilities	25,476	29,729	35,542	26,993	3,007
Total Current Liabilities	82,298	88,576	99,823	70,691	21,852
Long-Term Debt	23,908	24,035	26,183	25,091	942.84
Long-Term Leases	539.95	622.23	334.14	202.84	193.97
Long-Term Deferred Tax Liabilities	10.45	10.45	10.45	1,365	-
Other Long-Term Liabilities	1,117	1,529	1,296	6,425	849.76
Total Liabilities	107,874	114,774	127,646	103,774	23,838
Common Stock	4,997	4,907	4,907	4,907	4,907
Additional Paid-In Capital	65,047	62,139	62,386	62,386	62,397
Retained Earnings	30,773	30,375	29,129	24,305	15,848
Treasury Stock	-1.16	-1.16	-1.16	-1.16	-1.16
Comprehensive Income & Other	0	-0	0	0	0
Total Common Equity	100,815	97,420	96,422	91,597	83,150
Minority Interest	-161.03	79.38	1,035	725.74	-
Shareholders' Equity	100,654	97,499	97,456	92,323	83,150
Total Liabilities & Equity	208,528	212,273	225,102	196,097	106,989
Total Debt	57,868	65,312	78,780	59,339	7,852
Net Cash (Debt)	-19,285	-18,488	-13,947	35,632	31,407
Net Cash Growth	-	-	-	13.45%	-
Net Cash Per Share	-392.62	-376.77	-284.24	695.44	712.02
Filing Date Shares Outstanding	49.97	49.07	49.07	49.07	49.07
Total Common Shares Outstanding	49.97	49.07	49.07	49.07	49.07
Working Capital	20,887	16,613	24,169	72,202	55,063
Book Value Per Share	2017.67	1985.36	1965.01	1866.70	1694.56
Tangible Book Value	99,467	96,091	95,030	90,274	82,728
Tangible Book Value Per Share	1990.68	1958.28	1936.66	1839.72	1685.95
Land	20,224	20,224	19,837	15,613	3,997
Buildings	38,047	38,047	36,673	11,300	8,252
Machinery	31,311	30,295	22,297	11,051	7,554
Construction In Progress	1.44	624.1	6,407	13,388	9,214

Updated Nov 13, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.